Grozinsky-Glasberg S - Search Results

1

Appendiceal neuroendocrine neoplasms: diagnosis and management.

Alexandraki KI, Kaltsas GA, Grozinsky-Glasberg S, Chatzellis E, Grossman AB. Alexandraki KI, et al. Endocr Relat Cancer. 2016 Jan;23(1):R27-41. doi: 10.1530/ERC-15-0310. Epub 2015 Oct 19. Endocr Relat Cancer. 2016. PMID: 26483424 Review.

2

Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.

Grozinsky-Glasberg S, Franchi G, Teng M, Leontiou CA, Ribeiro de Oliveira A Jr, Dalino P, Salahuddin N, Korbonits M, Grossman AB. Grozinsky-Glasberg S, et al. Neuroendocrinology. 2008;87(3):168-81. doi: 10.1159/000111501. Epub 2007 Nov 16. Neuroendocrinology. 2008. PMID: 18025810

3

The role of somatostatin analogues in the treatment of neuroendocrine tumours.

Grozinsky-Glasberg S, Grossman AB, Korbonits M. Grozinsky-Glasberg S, et al. Mol Cell Endocrinol. 2008 May 14;286(1-2):238-50. doi: 10.1016/j.mce.2007.10.006. Epub 2007 Oct 13. Mol Cell Endocrinol. 2008. PMID: 18037561 Review.

4

Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.

Grozinsky-Glasberg S, Shimon I, Korbonits M, Grossman AB. Grozinsky-Glasberg S, et al. Endocr Relat Cancer. 2008 Sep;15(3):701-20. doi: 10.1677/ERC-07-0288. Epub 2008 Jun 4. Endocr Relat Cancer. 2008. PMID: 18524947 Review.

5

Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours.

Grozinsky-Glasberg S, Kaltsas G, Gur C, Gal E, Thomas D, Fichman S, Alexandraki K, Barak D, Glaser B, Shimon I, Gross DJ. Grozinsky-Glasberg S, et al. Eur J Endocrinol. 2008 Oct;159(4):475-82. doi: 10.1530/EJE-08-0420. Epub 2008 Jul 28. Eur J Endocrinol. 2008. PMID: 18662970 Clinical Trial.

6

Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.

Dworakowska D, Wlodek E, Leontiou CA, Igreja S, Cakir M, Teng M, Prodromou N, Góth MI, Grozinsky-Glasberg S, Gueorguiev M, Kola B, Korbonits M, Grossman AB. Dworakowska D, et al. Endocr Relat Cancer. 2009 Dec;16(4):1329-38. doi: 10.1677/ERC-09-0101. Epub 2009 Jul 20. Endocr Relat Cancer. 2009. PMID: 19620247

7

Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma.

Druce M, Chung TT, Grozinsky-Glasberg S, Gross DJ, Grossman AB. Druce M, et al. Clin Endocrinol (Oxf). 2012 Jul;77(1):154-5. doi: 10.1111/j.1365-2265.2011.04296.x. Clin Endocrinol (Oxf). 2012. PMID: 22103914 No abstract available.

8

New drugs in the therapy of neuroendocrine tumors.

Grozinsky-Glasberg S, Gross DJ. Grozinsky-Glasberg S, et al. J Endocrinol Invest. 2012 Nov;35(10):930-6. doi: 10.3275/8651. Epub 2012 Oct 9. J Endocrinol Invest. 2012. PMID: 23047256 Review.

9

Current size criteria for the management of neuroendocrine tumors of the appendix: are they valid? Clinical experience and review of the literature.

Grozinsky-Glasberg S, Alexandraki KI, Barak D, Doviner V, Reissman P, Kaltsas GA, Gross DJ. Grozinsky-Glasberg S, et al. Neuroendocrinology. 2013;98(1):31-7. doi: 10.1159/000343801. Epub 2012 Nov 22. Neuroendocrinology. 2013. PMID: 23051855 Review.

10

Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study.

Thomas D, Tsolakis AV, Grozinsky-Glasberg S, Fraenkel M, Alexandraki K, Sougioultzis S, Gross DJ, Kaltsas G. Thomas D, et al. Eur J Endocrinol. 2013 Jan 17;168(2):185-93. doi: 10.1530/EJE-12-0836. Print 2013 Feb. Eur J Endocrinol. 2013. PMID: 23132699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters